Brain Health

Standard prediction models that assess an individual’s risk of developing dementia and how to prevent it are limited in their ability to do so, showing high error rates and a higher chance of receiving a false-positive result, according to a recent study.

Study evaluates the interaction between excessive salt intake and hypertension, cognitive dysfunction, and dementia.

Neuromyelitis optica spectrum disorder is an autoimmune disease characterized by severe attacks of optic neuritis and/or myelitis, leading to possible visual loss, paralysis, cognitive impairment, sensory deficits, bladder dysfunction, and even mortality.

Recent debates have surrounded whether cognitive deficits, specifically in middle-aged patients, may be driven by cardiovascular and metabolic comorbidities instead of distinct obstructive sleep apnea processes.

Untreated hearing loss can affect communication, loneliness, and lead to severe illness, such as dementia.

The steroid could be more effective for veterans with post-traumatic stress disorder who do not have a history of traumatic brain injury.

Anxiety disorders create social and economic burdens as the availability of effective anxiolytic treatments are low.

Long-term data show that early treatment with ofatumumab decreased confirmed disability worsening in nearly all study patients with relapsing multiple sclerosis.

Many patients with post-COVID-19 condition reported perceived cognitive deficits early during their COVID-19 infection as well.

As demand increases, pharmacies can diversify by offering brain-function assessments to patients.

A novel collaboration between the University of Pennsylvania and US Anesthesia Partners is working to drive evidence-based change in benzodiazepine use.

The impact that socioeconomic inequities can have on a child’s hippocampal volume may have implications for their success and experience pursuing educational endeavors.

Lack of awareness, or anosognosia, may be present up to 2 to 3 years before an Alzheimer dementia diagnosis is made.

There are common symptoms experienced in the workplace that may be linked to hormones instead of stress.

Comorbidities and cognitive impairment worsen non-adherence to anti-seizure medications in older adults.

A combination of cognitive behavioral therapy and medication had the most profound and stable result for patients suffering from insomnia.

Investigators suggest that a checklist completed by physicians and family members of individuals with severe acute brain injury may improve management needs.

Six weeks after infusion of GD2-CART01, 9 of 27 patients (33%) with relapsed or refractory high-risk neuroblastoma had a complete response or maintained a complete response.

The FDA considers alcohol hangover as a disease, requiring treatments to be registered as drugs.

Clinicians are often focused on reducing brain damage after traumatic injury, but considering nutrition is an important component to healing.

Pharmacists are uniquely positioned to interact with patients who may be seeking an OTC drug or supplement as first-line therapy for short sleep duration.

For chronic cases, encourage patients to seek medical care from their primary health care providers.

It is still unclear whether comorbidities have similar negative effects on cognition beyond those directly caused by obstructive sleep apnea.

Among those without HIV, the analyses found that respondents with a history of COVID-19 performed worse on processing speed than those who had never had COVID-19.

As more drugs gain coverage, decision-makers will need to more accurately diagnose Alzheimer disease, especially in the community setting.

Strong interprofessional team helps ensure safe transitions and minimize adverse events, medication errors

Perceived stress and cognitive performance are independently associated. Stress can also increase the risk of worsening cognition.

Eli Lilly treatment targets soluble amyloid beta and did not clear plaque or halt accumulation of amyloid in individuals treated with the drug in the A4 study.

The study clarifies why serotonin-based therapeutics, such as selective serotonin reuptake inhibitors, do not promote neuroplasticity in the same ways as psychedelics and other psychoplastogenic therapeutics.

Sodium oxybate is currently being studied for long-term safety and tolerability in the open label RESTORE clinical study in adults with narcolepsy.